Blood, antisera, vaccines, toxins and cultures in   Austria

Exports In 2020, Austria exported $4.96B in Blood, antisera, vaccines, toxins and cultures, making it the 11th largest exporter of Blood, antisera, vaccines, toxins and cultures in the world. At the same year, Blood, antisera, vaccines, toxins and cultures was the 3rd most exported product in Austria. The main destination of Blood, antisera, vaccines, toxins and cultures exports from Austria are: Poland ($682M), United States ($639M), Germany ($606M), Belgium ($549M), and Italy ($390M).

The fastest growing export markets for Blood, antisera, vaccines, toxins and cultures of Austria between 2019 and 2020 were Poland ($428M), Belgium ($86.6M), and United States ($62.3M).

Imports In 2020, Austria imported $3.69B in Blood, antisera, vaccines, toxins and cultures, becoming the 14th largest importer of Blood, antisera, vaccines, toxins and cultures in the world. At the same year, Blood, antisera, vaccines, toxins and cultures was the 4th most imported product in Austria. Austria imports Blood, antisera, vaccines, toxins and cultures primarily from: United States ($1.06B), Germany ($791M), Switzerland ($442M), France ($354M), and Italy ($320M).

The fastest growing import markets in Blood, antisera, vaccines, toxins and cultures for Austria between 2019 and 2020 were Germany ($165M), Switzerland ($136M), and France ($102M).

Tariffs In 1990, the average tariff for Austria in Blood, antisera, vaccines, toxins and cultures was 4.18%. The countries with the highest import tariffs for Blood, antisera, vaccines, toxins and cultures were Mayotte (Most Favoured Nation duty rate treatement, 7.08%), South Sudan (Most Favoured Nation duty rate treatement, 7.08%), South Africa (Most Favoured Nation duty rate treatement, 7.08%), Antarctica (Most Favoured Nation duty rate treatement, 7.08%), and French South Antarctic Territory (Most Favoured Nation duty rate treatement, 7.08%).